Retinoids act as multistep modulators of the major histocompatibility class I presentation pathway and sensitize neuroblastomas to cytotoxic lymphocytes.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Cancer Research

• Publication date

  2003-11-15

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 14633733
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Variable receptors controlling activation and inhibition of NK cells.

  2002cited by this paper
• Immunobiology of tumor necrosis factor receptor superfamily

  2002cited by this paper
• The cell biology of MHC class I antigen presentation.

  2002cited by this paper
• Functional significance of the perforin/granzyme cell death pathway

  2002cited by this paper
• Death Receptor Ligands in Tumors

  2002cited by this paper
• Regulation of Calreticulin Expression during Induction of Differentiation in Human Myeloid Cells

  2002cited by this paper
• Adjuvants and the promotion of Th1-type cytokines in tumour immunotherapy

  2002cited by this paper
• Contemporary therapeutic options for children with high risk neuroblastoma.

  2002cited by this paper
• Surface antigens of human embryonic stem cells: changes upon differentiation in culture *

  2002cited by this paper
• Tumor necrosis factor-alpha induces coordinated changes in major histocompatibility class I presentation pathway, resulting in increased stability of class I complexes at the cell surface.

  2001cited by this paper
• Retinoid therapy of childhood cancer.

  2001cited by this paper
• Ligands for natural killer cell receptors: redundancy or specificity

  2001cited by this paper
• A listing of human tumor antigens recognized by T cells

  2001cited by this paper
• Monoclonal antibody-based therapy for neuroblastoma

  2000influential reference
• Differentiating agents in pediatric malignancies: Retinoids in neuroblastoma

  2000cited by this paper
• Differential Influence on Cytotoxic T Lymphocyte Epitope Presentation by Controlled Expression of Either Proteasome Immunosubunits or Pa28

  2000influential reference
• The Use of Cytotoxic T Cells for the Prevention and Treatment of Epstein-Barr Virus Induced Lymphoma in Transplant Recipients

  2000cited by this paper
• Distinct proteolytic processes generate the C and N termini of MHC class I-binding peptides.

  1999cited by this paper
• Proteolysis and class I major histocompatibility complex antigen presentation

  1999cited by this paper
• The role of human melanoma cell ICAM-1 expression on lymphokine activated killer cell-mediated lysis, and the effect of retinoic acid

  1999cited by this paper
• Antigen presentation by MHC class I and its regulation by interferon gamma.

  1999cited by this paper
• Evidence for successive peptide binding and quality control stages during MHC class I assembly.

  1998cited by this paper
• Effects of retinoic acid combined with interferon‐gamma on the expression of major‐histocompatibility‐complex molecules and intercellular adhesion molecule‐1 in human cervical cancer

  1998cited by this paper
• Retinoic acid up-regulates the expression of major histocompatibility complex molecules and adhesion/costimulation molecules (specifically, intercellular adhesion molecule ICAM-1) in human cervical cancer.

  1998cited by this paper
• The clonal composition of a peptide-specific oligoclonal CTL repertoire selected in response to persistent EBV infection is stable over time.

  1998cited by this paper
• All-trans retinoic acid decreases susceptibility of a gastric cancer cell line to lymphokine-activated killer cytotoxicity.

  1997cited by this paper
• HL‐60 myeloid leukaemia cells acquire immunostimulatory capability upon treatment with retinoic acid: analysis of the responding population and mechanism of cytotoxic lymphocyte activation

  1996cited by this paper
• Functional and molecular characterization of tumour-infiltrating lymphocytes and clones thereof from a major-histocompatibility- complex-negative human tumour: neuroblastoma

  1996influential reference
• Peptide antigen production by the proteasome: complexity provides efficiency.

  1996cited by this paper
• Interferon-γ induces different subunit organizations and functional diversity of proteasomes

  1994cited by this paper
• Retinoic acid-stimulated intercellular adhesion molecule-1 expression on SK-N-SH cells: calcium/calmodulin-dependent pathway.

  1994cited by this paper
• Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas

  1994cited by this paper
• Interferon-gamma induces different subunit organizations and functional diversity of proteasomes.

  1994cited by this paper
• Tumor rejection antigens and tumor specific cytotoxic T lymphocytes.

  1994cited by this paper
• Interactions between interferon gamma and retinoic acid with transforming growth factor beta in the induction of immune recognition molecules.

  1993cited by this paper
• Expression of β2m‐Free HLA Class I Heavy Chains in Neuroblastoma Cell Lines

  1993cited by this paper
• Expression of beta 2m-free HLA class I heavy chains in neuroblastoma cell lines.

  1993cited by this paper
• Interactions between interferon γ and retinoic acid with transforming growth factor β in the induction of immune recognition molecules

  1993cited by this paper
• The fate of the three subunits of major histocompatibility complex class I molecules

  1992cited by this paper
• Peptide binding to empty HLA-B27 molecules of viable human cells

  1991cited by this paper
• Regulation by retinoic acid of ICAM-1 expression on human tumor cell lines.

  1991cited by this paper
• Surface appearance and instability of empty H-2 class I molecules under physiological conditions.

  1991cited by this paper
• A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor

  1989cited by this paper
• Differentiation-dependent sensitivity of human B-cell-derived lines to major histocompatibility complex-restricted T-cell cytotoxicity.

  1986cited by this paper

• MHC Class I Downregulation in Cancer: Underlying Mechanisms and Potential Targets for Cancer Immunotherapy

  2020cites this paper
• Immunoepigenetics Combination Therapies: An Overview of the Role of HDACs in Cancer Immunotherapy

  2019cites this paper
• Novel Inflammatory Mediators in Neuroblastoma Tumorigenesis

  2019cites this paper
• Immunological Effects of Epigenetic Modifiers

  2019cites this paper
• Nedd4-Binding Protein 1 and TNFAIP3-Interacting Protein 1 Control MHC-1 Display in Neuroblastoma.

  2018cites this paper
• Neuroblastoma

  2018cites this paper
• The metastasis suppressor RARRES3 as an endogenous inhibitor of the immunoproteasome expression in breast cancer cells

  2017cites this paper
• Level of Retinol Deposit and Cervical Cancer

  2017cites this paper
• All-trans-retinoic acid and CD38 ligation differentially regulate CD1d expression and α-galactosylceramide-induced immune responses.

  2015cites this paper
• Approaches to Passive and Active Vaccination against Neuroblastoma

  2015cites this paper
• Coordinated regulation of the immunoproteasome subunits by PML/RARα and PU.1 in acute promyelocytic leukemia

  2014cites this paper
• Retinoid Signaling in Cancer and its Promise for Therapy

  2013cites this paper
• Expression of NTRK1/TrkA affects immunogenicity of neuroblastoma cells

  2013cites this paper
• Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment.

  2012cites this paper
• Influência do bloqueio do receptor do peptídeo liberador de gastrina em combinação com inibição de histona deacetilase sobre a proliferação de células de neuroblastoma

  2011cites this paper
• Immunotherapy of MHC class I-deficient tumors.

  2010cites this paper
• Molecular Characteristics of Neuroblastoma with Special Reference to Novel Prognostic Factors and Diagnostic Applications

  2009cites this paper
• Examining different levels of prevention of birth defects and fetal alcohol spectrum disorder.

  2009cites this paper
• Non‐transmissible Sendai virus encoding granulocyte macrophage colony‐stimulating factor is a novel and potent vector system for producing autologous tumor vaccines

  2008cites this paper
• Differentiation induced by physiological and pharmacological stimuli leads to increased antigenicity of human neuroblastoma cells

  2008cites this paper
• Molecular mechanisms of MHC class I abnormalities and APM components in human tumors

  2008cites this paper
• Different regulation of MHC Class I antigen processing components in human tumors

  2008cites this paper
• Soluble factors released by activated cytotoxic T lymphocytes interfere with death receptor pathways in neuroblastoma

  2008cites this paper
• Expression and functional analysis of human leukocyte antigen class I antigen-processing machinery in medulloblastoma.

  2007cites this paper
• RAR and RXR modulation in cancer and metabolic disease

  2007cites this paper
• Combination of physical activity, nutrition, or other metabolic factors and vaccine response.

  2007cites this paper
• Neuroblastoma as a target for effector mechanisms of the immune system

  2007cites this paper
• Manipulating Immunological Checkpoints to Maximize Antitumor Immunity

  2006cites this paper
• Induction of Efficient Antitumor Immunity Using Dendritic Cells Activated by Recombinant Sendai Virus and Its Modulation by Exogenous IFN-β Gene1

  2006cites this paper
• Cytotoxic T Lymphocytes Induce Caspase-Dependent and -Independent Cell Death in Neuroblastomas in a MHC-Nonrestricted Fashion1

  2006cites this paper
• Cytotoxic T Lymphocytes Induce Caspase-Dependent and -Independent Cell Death in Neuroblastomas in a MHC-Nonrestricted Fashion

  2006cites this paper
• Tumor mRNA-transfected dendritic cells stimulate the generation of CTL that recognize neuroblastoma-associated antigens and kill tumor cells: immunotherapeutic implications.

  2006cites this paper
• Retinoic acid elicits cytostatic, cytotoxic and immunomodulatory effects on uveal melanoma cells

  2006cites this paper
• MHC-Nonrestricted Fashion Death in Neuroblastomas in a Caspase-Dependent and-Independent Cell Cytotoxic T Lymphocytes Induce

  2006cites this paper
• The role of gangliosides in fenretinide-induced apoptosis of neuroblastoma.

  2005cites this paper
• Increasing the intracellular availability of all-trans retinoic acid in neuroblastoma cells

  2005cites this paper
• Trefoil Factor 2 (Tff2) Deficiency in Murine Digestive Tract Influences the Immune System

  2005cites this paper
• Multiple defects of the antigen-processing machinery components in human neuroblastoma: immunotherapeutic implications

  2005cites this paper
• Experimental Therapeutics and Preclinical Models

  2005cites this paper
• Retinoids: potential in cancer prevention and therapy

  2004cites this paper